Gang Inflated Bio Stock with "Positive News," Earned Hundreds of Billions, Receive Suspended Sentences
Accomplice Also Receives Suspended Prison Sentence and Fine of 25 Billion Won
A group of individuals who inflated stock prices with false positive information related to the bio business and secured approximately 30 billion won in illicit gains have received suspended prison sentences in the first trial.
On July 14, the 15th Criminal Division of the Seoul Southern District Court (Presiding Judge Noh Yookyung) sentenced Mr. Lee, the CEO of a venture investment firm who had been indicted without detention on charges of fraudulent unfair trading under the Capital Markets Act and embezzlement under the Act on the Aggravated Punishment of Specific Economic Crimes, to two years and six months in prison, suspended for four years, and a fine of five billion won. The court also ordered the forfeiture of 2.533 billion won. His accomplice, Mr. Jeon, who faced similar charges without detention, was sentenced to two years and six months in prison, also suspended for four years, and a fine of 25 billion won.
In addition, Mr. Man, Mr. Jang, and Mr. Kim, who were also indicted without detention on charges of perjury, each received a sentence of one year in prison, suspended for two years. Another accomplice, Mr. Lee, received a sentence of eight months in prison, suspended for two years, along with eighty hours of community service. Mr. Na, the head of a sand washing and sales company who was charged with suborning perjury, did not appear in court. The court stated that the sentencing for Mr. Na would be handled separately.
Mr. Lee, CEO of the venture investment firm, and others were brought to trial on charges of conspiring with Mr. Na to disseminate news in 2018 touting a new bio-pharmaceutical business, artificially boosting the company's stock price, and falsely announcing that they had attracted funds from a major international fund—resulting in illicit gains of approximately 30 billion won. Mr. Lee was also accused of embezzling 850 million won from company funds and participating in stock price manipulation by using borrowed-name accounts.
The court stated, "The dissemination of false press releases constitutes fraudulent unfair trading as prohibited by the Capital Markets Act," and added, "It appears that the intention was not to actually conduct a bio business, but rather to boost the stock price and profit from convertible bonds acquired as a result. All charges have been found guilty."
Regarding the embezzlement charges, the court commented, "The defendant exploited his position as CEO by failing to follow proper procedures such as obtaining board approval and it is difficult to consider the actions as being for the victim company's benefit. While he emphasizes that the funds were fully repaid later, the embezzlement had already occurred, so this does not affect the validity of the embezzlement charge."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The court explained its reasoning for the sentencing, stating, "The offenses severely undermined investor trust and constituted crimes of significant social impact, making punishment necessary. Considering the amount of illicit gains, the severity of the crimes is substantial, and there remains unrecovered damage to the victims."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.